Disposition of mitomycin C after local intraarterial application.
Theisohn
M
M
Universitätsklinik Köln, Germany.
Fischbach
R
R
Joseph
G
G
Biederbick
W
W
Rump
A F
AF
Botvinik-Helling
S
S
Bäcker
A
A
Woschee
U
U
Heindel
W
W
Lackner
K
K
Klaus
W
W
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D001682:Biological Availability; D016461:Chemoembolization, Therapeutic; D015179:Colorectal Neoplasms / Q000473:pathology; D006801:Humans; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000378:metabolism / Q000556:secondary; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin